Innovative BioCeramix, Inc
IBC is a technologically advanced medical device company located
in Vancouver, British Columbia Canada.  IBC is certified to ISO
13485 and is committed to developing high quality medical devices
for dental and orthopaedic applications based on cutting-edge
biomaterial technologies.  Through dedicated research,
manufacturing, and marketing activities at our 6,000 sq.ft GMP
facility, our goal is to design and develop medical devices based on
biological cements (calcium phosphate cement (CPC) and calcium
phosphate silicate cement) and bioceramics.  IBC is a pioneer in the
field of development and manufacture of biomaterials and medical
devices that will benefit patients and provide convenience for the
professional personnel.

IBC is a privately owned North American company, which was
founded by a group of partners with considerable experience in
academic research and development of bioceramic technologies,
business development specializing in the biomedical industry and in
the distribution of dental products.  IBC’s partners build on synergy of
their combined talents, experience, expertise and business
connections, and intend to successfully commercialize and market
their novel dental and orthopaedic medical devices.  

IBC has successfully developed and manufactures BioAggregate
Root Canal Repair Filling Material, iRoot SP injectable root canal
sealer, iRoot BP, and iRoot BP Plus advanced root canal repair and
filling materials, which is designated for endodontic applications.  
These products received the pre-market approval from US FDA, CE
Mark, and Health Canada. IBC is currently developing three
additional next generation dental and orthopaedic products.
IBC management team
consists of a group of
executive managers
experienced in  research,
product development,
manufacturing, finance, and
marketing in medical device
industry.
IBC has successfully
develop the novel
bioceramic technologies and
next generation & revolution
dental products to change
the dream of dentist and
patient into a reality.
IBC owns the 6,000 sq.ft
GMP facilities for research &
development, testing, and
manufacturing medical
devices.
IBC products received the
pre-market approval from US
FDA, CE Mark, and Health
Canada
Innovative BioCeramix, Inc. (IBC)